Table 1.
Samples tested for telomerase reverse transcriptase (TERT) promoter mutations 1.
| Tumor Type | No. of Tumors | No. of Tumors Mutated |
|---|---|---|
| B-cell acute lymphoblastic leukemia | 12 | 0 |
| Burkitt lymphoma | 9 | 0 |
| Chronic lymphocytic leukemia | 11 | 0 |
| Diffuse large B-cell lymphoma | 9 | 0 |
| Follicular lymphoma | 13 | 0 |
| Lymphoplasmacytic lymphoma | 7 | 0 |
| Mantle cell lymphoma | 12 | 0 |
| Marginal zone lymphoma | 16 | 0 |
| Myeloma/plasmacytoma | 9 | 0 |
| Plasmablastic lymphoma | 7 | 0 |
1 Glioblastoma tissues were used as positive controls (n = 11); reactive lymph nodes (n = 13) were used as negative controls for formalin-fixed paraffin-embedded (FFPE) samples; normal bone marrow samples (n = 13) were used as negative controls for B-cell acute lymphoblastic leukemia (B-ALL) samples.